There is an association between the expression of miR-31-5p and shortened PFS in patients with metastatic CRC treated with anti-EGFR therapy [122]; thus, it has demonstrated a strong diagnostic ability for CRC in serum [123]. The gene discussed is EGFR; the disease is colorectal carcinoma.